newsfilter
← Latest News
GlobeNewswire·

Oragenics Completes Approximately $16.5 Million Offering

SARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE:OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful